Study out of Israel:
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel | NEJM
"Conclusions
Rates of confirmed SARS-CoV-2 infection and severe Covid-19 were lower after a fourth dose of BNT162b2 vaccine than after only three doses. Protection against confirmed infection appeared short-lived, whereas protection against severe illness did not wane during the study period."
and an article about it:
Protection against COVID-19 infection improves after fourth vaccine dose but wanes quickly: study
"A new study in Israel has found that the fourth dose of the Pfizer-BioNTech COVID-19 vaccine improves protection against infection and severe COVID-19; however, protection against confirmed infection appears to be short-lived.
The study, published in the New England Journal of Medicine on Tuesday, found that the effectiveness against COVID-19 infection in the fourth week after receipt of the fourth dose was lower when compared to protection after the third dose of the vaccine.
It added that protection against severe illness did not wane during the six weeks after the fourth dose was administered and found that the rate of confirmed infection in the fourth week after was lower than that in the group with three vaccine doses.
However, the study added that protection against infection waned in later weeks.
Israel was the first country to begin administering a fourth dose. The study, conducted by the Sheba Medical Center, included more than 1.25 million vaccinated people in Israel from Jan. 10 to March 2.
It included those who were 60 years of age or older and had received three doses of Pfizer-BioNTech COVID-19 vaccine at least four months before. It took place as the omicron variant led to a winter surge of coronavirus cases around the world."
______________________________
I'm hoping for boosters that target Omicron better.